Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4531 AL 4545

Therapeutic strategies for the treatment of tauopathies: Hopes and challenges

Khanna MR, Kovalevich J, Lee VM, Trojanowski JQ, Brunden KR.

Alzheimers Dement. 2016 Oct;12(10):1051-1065. doi: 10.1016/j.jalz.2016.06.006.

Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer's Disease Immunotherapy

Liu J, Yang B, Ke J, Li W, Suen WC.

Drugs Aging. 2016 Oct;33(10):685-697. doi: 10.1007/s40266-016-0406-x.

Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal

Kuruva CS, Reddy PH.

Drug Discov Today. 2017 Feb;22(2):223-233. doi: 10.1016/j.drudis.2016.10.010. Epub 2016 Oct 27.

The amyloid cascade hypothesis: are we poised for success or failure?

Karran E, De Strooper B.

J Neurochem. 2016 Oct;139 Suppl 2:237-252. doi: 10.1111/jnc.13632. Epub 2016 Jun 3.

Molecular and Therapeutic Targets of Genistein in Alzheimer's Disease

Devi KP, Shanmuganathan B, Manayi A, Nabavi SF, Nabavi SM.

Mol Neurobiol. 2017 Nov;54(9):7028-7041. doi: 10.1007/s12035-016-0215-6. Epub 2016 Oct 28.

Treatment of epilepsy for people with Alzheimer's disease

Liu J, Wang LN, Wu LY, Wang YP.

Cochrane Database Syst Rev. 2016 Nov 2;11(11):CD011922. doi: 10.1002/14651858.CD011922.pub2.

Alzheimer's disease: cerebrolysin and nanotechnology as a therapeutic strategy

Sharma HS, Muresanu DF, Sharma A.

Neurodegener Dis Manag. 2016 Dec;6(6):453-456. doi: 10.2217/nmt-2016-0037. Epub 2016 Nov 9.

The road to restoring neural circuits for the treatment of Alzheimer's disease

Canter RG, Penney J, Tsai LH.

Nature. 2016 Nov 10;539(7628):187-196. doi: 10.1038/nature20412.

Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review

Wang ZY, Liu JG, Li H, Yang HM.

Am J Chin Med. 2016;44(8):1525-1541. doi: 10.1142/S0192415X16500853. Epub 2016 Nov 16.

Pharmacotherapies for sleep disturbances in dementia

McCleery J, Cohen DA, Sharpley AL.

Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub3.

Inflammasomes, hormesis, and antioxidants in neuroinflammation: Role of NRLP3 in Alzheimer disease

Pennisi M, Crupi R, Di Paola R, Ontario ML, Bella R, Calabrese EJ, Crea R, Cuzzocrea S, Calabrese V.

J Neurosci Res. 2017 Jul;95(7):1360-1372. doi: 10.1002/jnr.23986. Epub 2016 Nov 8.

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ, Schelter BO, Davis CS, Staff RT, Bracoud L, Shamsi K, Storey JM, Harrington CR, Wischik CM.

Lancet. 2016 Dec 10;388(10062):2873-2884. doi: 10.1016/S0140-6736(16)31275-2. Epub 2016 Nov 16.

Molecular Anti-inflammatory Mechanisms of Retinoids and Carotenoids in Alzheimer's Disease: a Review of Current Evidence

Mohammadzadeh Honarvar N, Saedisomeolia A, Abdolahi M, Shayeganrad A, Taheri Sangsari G, Hassanzadeh Rad B, Muench G.

J Mol Neurosci. 2017 Mar;61(3):289-304. doi: 10.1007/s12031-016-0857-x. Epub 2016 Nov 18.

A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease

Sameem B, Saeedi M, Mahdavi M, Shafiee A.

Eur J Med Chem. 2017 Mar 10;128:332-345. doi: 10.1016/j.ejmech.2016.10.060. Epub 2016 Oct 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias